Analysen von Eliana Merle
| 05.08.25 | BioNTech (ADRs) Neutral | UBS AG | |
| 07.05.25 | BioNTech (ADRs) Neutral | UBS AG | |
| 11.03.25 | BioNTech (ADRs) Neutral | UBS AG | |
| 02.10.24 | BioNTech (ADRs) Neutral | UBS AG | |
| 18.09.24 | BioNTech (ADRs) Neutral | UBS AG | |
| 10.05.24 | BioNTech (ADRs) Neutral | UBS AG | |
| 20.03.24 | BioNTech (ADRs) Neutral | UBS AG | |
| 09.01.24 | BioNTech (ADRs) Neutral | UBS AG | |
|
Werbung
|
|||
| 14.12.23 | BioNTech (ADRs) Neutral | UBS AG | |
| 28.11.23 | BioNTech (ADRs) Neutral | UBS AG | |
| 02.11.23 | Moderna Buy | UBS AG | |
| 23.10.23 | Moderna Buy | UBS AG | |
| 16.10.23 | BioNTech (ADRs) Neutral | UBS AG | |
| 06.06.23 | BioNTech (ADRs) Neutral | UBS AG | |
| 01.02.23 | BioNTech (ADRs) Neutral | UBS AG | |
| 19.01.23 | CureVac Buy | UBS AG | |
| 15.11.22 | BioNTech (ADRs) Neutral | UBS AG | |
| 30.06.22 | BioNTech (ADRs) Neutral | UBS AG | |
| 23.09.21 | BioNTech (ADRs) Neutral | UBS AG | |